NIH-funded research R01 grant

Early warning monitors for very small premature babies in the NICU

Official title: Predictive informatics monitoring in the Neonatal Intensive Care Unit

Funded at University of Virginia · NIH-11327642 · Data updated 2026-11-12

Uses advanced computer analysis of bedside monitor data to find early signs of infection and serious gut disease in very low birth weight premature infants.

More Intensive Care research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Virginia
NIH-funded
Lab location1 site (Charlottesville, United States)
Project startJuly 10, 2014
Project endApril 30, 2027
Funding year2026
Award (this year)$656,442
NIH project number5R01HD072071-12
Project IDNIH-11327642 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are very low birth weight (VLBW) premature infants cared for in participating neonatal intensive care units who have continuous bedside monitoring.

Less likely to help

Full-term infants, babies not admitted to a participating NICU, or infants without continuous monitor data are unlikely to benefit from this project.

What this research studies

This project uses the same bedside monitor data that already watch your baby—heart rate and oxygen levels—and applies advanced time-series and machine-learning methods to spot subtle changes before symptoms appear. The team builds on the HeRO monitor, which previously reduced sepsis deaths, and is adding oxygen saturation patterns and combined heart rate–SpO2 trends to improve early detection of sepsis and necrotizing enterocolitis (NEC). Researchers are testing these algorithms across different hospitals to make sure they work for babies with different demographics and care practices. If your baby is in a participating NICU, the goal is to provide earlier alerts so clinicians can act sooner.

Why it matters

Potential benefit: Could enable earlier alarms and treatment for sepsis or NEC, potentially reducing deaths and long-term complications in very small premature infants.

How similar studies have gone: A prior randomized trial of the HeRO monitor reduced sepsis-related mortality by about 40% in 3,003 VLBW infants, and this project builds on that successful approach.

Where this research is happening

  • University of Virginia
    Charlottesville, United States
    Active

Researchers

  • Principal investigator: Fairchild, Karen D — University of Virginia
  • Study coordinator: Fairchild, Karen D

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.